AUSTIN BROWN to Follow-Up Studies
This is a "connection" page, showing publications AUSTIN BROWN has written about Follow-Up Studies.
Connection Strength
0.441
-
Toxicity profile of high-dose methotrexate in young children with central nervous system tumors. Pediatr Blood Cancer. 2024 Oct; 71(10):e31213.
Score: 0.110
-
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatr Blood Cancer. 2024 Sep; 71(9):e31169.
Score: 0.110
-
Admixture Mapping Reveals Candidate Regions for Methotrexate Neurotoxicity Susceptibility: A Reducing Disparities in Acute Leukemia Consortium Report. Pediatr Blood Cancer. 2026 Oct; 73(10):e70554.
Score: 0.032
-
Improved Early Referral in Long-Term Survivor Care With Institutional Standardized Practice Among Childhood Leukemia Survivors. Pediatr Blood Cancer. 2026 Sep; 73(9):e70461.
Score: 0.032
-
Clinical Correlates of Anxiety and Depression After Diagnosis of a Pediatric Brain Tumor. Pediatr Blood Cancer. 2026 Feb; 73(2):e70065.
Score: 0.030
-
Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among at-Risk Childhood Cancer Survivors in the US. Pediatr Blood Cancer. 2026 01; 73(1):e32124.
Score: 0.030
-
Delayed excretion of high-dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management. Pediatr Blood Cancer. 2025 Jan; 72(1):e31377.
Score: 0.028
-
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
Score: 0.028
-
Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
Score: 0.021
-
Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
Score: 0.020